Buscar resultados de ensayos clínicos
Lung Diseases, Interstitial - 29 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Pulmonary Rehabilitation in Interstitial Lung Disease Condición: Interstitial Lung Disease Fecha: 2005-09-13 Intervenciones: Behavioral: Pulmonary Rehabilitation |
Completed |
Nombre del estudio: Pulmonary Rehabilitation in Interstitial Lung Diseases Condición: Interstitial Lung Disease Fecha: 2009-04-15 Intervenciones: Other: Pulmonary Rehabilitation The intervention group will perform a 6 month pulmonary rehabilitation p |
Completed |
Nombre del estudio: Diagnostic Yield of Transbronchial Cryobiopsy in Diagnosis of Interstitial Lung Diseases Condición: Interstitial Lung Disease Fecha: 2014-08-26 Intervenciones: Other: Transbronchial lung cryobiopsy |
Active, not recruiting |
Nombre del estudio: Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung Disease Condición: Interstitial Lung Disease Fecha: 2013-09-03 Intervenciones:
|
Recruiting |
Nombre del estudio: Comparison of Transbronchial, Cryoprobe and VATS Biopsy For the Diagnosis of Interstitial Lung Disease (ILD) Condición: Interstitial Lung Disease Fecha: 2013-06-27 Intervenciones:
|
COMPLETED |
Nombre del estudio: Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment Condición: Lung Diseases, Interstitial Fecha: 2024-05-19 |
COMPLETED |
Nombre del estudio: Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease Condición: Lung Diseases, Interstitial Fecha: 2024-05-19 |
RECRUITING |
Nombre del estudio: Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation Condición: Lung Diseases, Interstitial Fecha: 2024-05-19 Intervenciones: CP Insight Watch (Actigraph, Pensacola, FL) is usually worn on the wrist.The watch captures and records continuous high-resolution raw accelerat |
RECRUITING |
Nombre del estudio: A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC Condición: Lung Diseases, Interstitial Fecha: 2024-05-19 Intervenciones: Standard-of-care treatment for st.IV NSCLC (no driver mutation, PD-L1 > 50%) |